Ad(GV)CD.10
Alternative Names: Cytosine deaminase gene therapy-GenVec; GV 1301Latest Information Update: 29 Jun 2017
At a glance
- Originator GenVec
- Class Antineoplastics; Cytosine deaminase flucytosine gene therapies; Pyrimidinones; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer metastases